As of 2025-10-30, the Relative Valuation of Harvard Bioscience Inc (HBIO) is (36.19) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.45 USD, the upside of Harvard Bioscience Inc based on Relative Valuation is -8205.9%.
The range of the Relative Valuation is (35.17) - (35.04) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 27.3x - 31.4x | 29.2x |
| Forward P/E multiples | 26.6x - 27.2x | 27.0x |
| Fair Price | (35.17) - (35.04) | (36.19) |
| Upside | -7976.4% - -7947.5% | -8205.9% |
| Date | P/E |
| 2025-10-28 | -0.31 |
| 2025-10-27 | -0.31 |
| 2025-10-24 | -0.32 |
| 2025-10-23 | -0.31 |
| 2025-10-22 | -0.31 |
| 2025-10-21 | -0.32 |
| 2025-10-20 | -0.31 |
| 2025-10-17 | -0.29 |
| 2025-10-16 | -0.31 |
| 2025-10-15 | -0.33 |
| 2025-10-14 | -0.33 |
| 2025-10-13 | -0.33 |
| 2025-10-10 | -0.33 |
| 2025-10-09 | -0.34 |
| 2025-10-08 | -0.34 |
| 2025-10-07 | -0.34 |
| 2025-10-06 | -0.34 |
| 2025-10-03 | -0.35 |
| 2025-10-02 | -0.36 |
| 2025-10-01 | -0.35 |
| 2025-09-30 | -0.34 |
| 2025-09-29 | -0.34 |
| 2025-09-26 | -0.34 |
| 2025-09-25 | -0.34 |
| 2025-09-24 | -0.35 |
| 2025-09-23 | -0.36 |
| 2025-09-22 | -0.37 |
| 2025-09-19 | -0.36 |
| 2025-09-18 | -0.37 |
| 2025-09-17 | -0.36 |
| 2025-09-16 | -0.38 |
| 2025-09-15 | -0.34 |
| 2025-09-12 | -0.34 |
| 2025-09-11 | -0.34 |
| 2025-09-10 | -0.35 |
| 2025-09-09 | -0.34 |
| 2025-09-08 | -0.35 |
| 2025-09-05 | -0.37 |
| 2025-09-04 | -0.36 |
| 2025-09-03 | -0.37 |
| 2025-09-02 | -0.38 |
| 2025-08-29 | -0.38 |
| 2025-08-28 | -0.40 |
| 2025-08-27 | -0.41 |
| 2025-08-26 | -0.42 |
| 2025-08-25 | -0.39 |
| 2025-08-22 | -0.38 |
| 2025-08-21 | -0.37 |
| 2025-08-20 | -0.37 |
| 2025-08-19 | -0.38 |